Whitehawk Therapeutics Stock (NASDAQ:WHWK)
Previous Close
$4.01
52W Range
$1.39 - $4.48
50D Avg
$2.95
200D Avg
$2.26
Market Cap
$183.80M
Avg Vol (3M)
$141.89K
Beta
0.64
Div Yield
-
WHWK Company Profile
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.